[The Proteus syndrome: a rare cause of pulmonary emphysema]

C Launois1, H Vallerand, J-M Perotin

  • 1Inserm UMRS 903, service des maladies respiratoires, hôpital Maison-Blanche, CHU de Reims, 45, rue Cognacq-Jay, 51092 Reims cedex, France.

Insights

Proteus syndrome, a rare genetic disorder from AKT1 mutations, can cause severe pulmonary emphysema. This case highlights a potential link between Proteus syndrome and lung disease, suggesting shared pathways with lymphangioleiomyomatosis.

Area of Science:

  • Genetics
  • Pulmonology
  • Oncology

Background:

  • Proteus syndrome is a rare genetic disorder characterized by tissue overgrowth, linked to somatic mosaic activating mutations in the AKT1 oncogene.
  • This condition involves abnormal development of bone, connective, and adipose tissues.

Observation:

  • A 25-year-old male with Proteus syndrome, diagnosed at 6 months, presented with asymmetric limb overgrowth and respiratory failure.
  • He developed severe bullous pulmonary emphysema, predominantly on the left, with mediastinal deviation, following a bronchopulmonary infection.

Findings:

  • The patient exhibited mild hypoxemia and severe airflow limitation with hyperinflation post-infection.
  • Pulmonary function tests revealed significantly reduced FEV1 and elevated residual volume, indicative of obstructive lung disease.

Implications:

  • Proteus syndrome is an exceptionally rare cause of pulmonary emphysema.
  • The exact pathophysiology of emphysema in Proteus syndrome remains unclear.
  • It is hypothesized that AKT1 activation may play a role in pulmonary cyst development and emphysema, similar to lymphangioleiomyomatosis.
Abstract

Related Concept Videos

Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
155
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
71
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
5.0K
Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
1.5K
Pulmonary Embolism I: Introduction01:19

Pulmonary Embolism I: Introduction

A blood clot, or thrombus, is a semi-solid mass composed of fibrin, platelets, and red blood cells. When it forms within a vessel, it can obstruct blood flow, known as thrombosis. If part of the clot detaches, it becomes an embolus that can travel and block distant vessels. When this occurs in the pulmonary arteries, it causes a condition known as pulmonary embolism (PE).Origin and ImpactMost often, the embolus originates from a thrombus in the deep veins of the lower limbs, a condition called...
65
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
77